title: An interview with Simon Wain-Hobson, PhD. Interview by Mark Mascolini.
authors.affiliation: Institut Pasteur, Paris, Cedex 15, France.
authors.forename: S
authors.initials: S
authors.lastname: Wain-Hobson
mesh_terms: D016915:AIDS Vaccines; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology; D016923:Cell Death; D003906:Developing Countries; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology* / Q000517:prevention & control; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology / Q000276:immunology*
chemical_list: D016915:AIDS Vaccines